Search research articles
Contact Us
Filters
Showing results (181-190 of 247) with videos related to
Page
of 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2024
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
March 2, 2023
A Scalable Platform for Fabricating Biodegradable Microparticles with Pulsatile Drug Release
Tyler P Graf, Sherry Yue Qiu, Dhruv Varshney, et al.
JCO Precision Oncology
|
August 17, 2022
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma
Ryon P Graf, Virginia Fisher, Richard S P Huang, et al.
The Oncologist
|
March 3, 2023
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay
Natalie Danziger, Ethan S Sokol, Ryon P Graf, et al.
The Prostate
|
March 14, 2022
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer
Emmanuel S Antonarakis, Marni Tierno, Virginia Fisher, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer
B Miron, G Li, J C F Quintanilha, et al.
JTO Clinical and Research Reports
|
September 12, 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC
Lee S Schwartzberg, Gerald Li, Khaled Tolba, et al.
Neurology
|
September 25, 1999
Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial
B Kremer, C M Clark, E W Almqvist, et al.
Journal of Circulating Biomarkers
|
March 15, 2021
Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer
David Lu, Rachel Krupa, Melissa Harvey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Chadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 247) with videos related to
Sort By:
Page
of 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2024
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
March 2, 2023
A Scalable Platform for Fabricating Biodegradable Microparticles with Pulsatile Drug Release
Tyler P Graf, Sherry Yue Qiu, Dhruv Varshney, et al.
JCO Precision Oncology
|
August 17, 2022
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma
Ryon P Graf, Virginia Fisher, Richard S P Huang, et al.
The Oncologist
|
March 3, 2023
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay
Natalie Danziger, Ethan S Sokol, Ryon P Graf, et al.
The Prostate
|
March 14, 2022
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer
Emmanuel S Antonarakis, Marni Tierno, Virginia Fisher, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer
B Miron, G Li, J C F Quintanilha, et al.
JTO Clinical and Research Reports
|
September 12, 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC
Lee S Schwartzberg, Gerald Li, Khaled Tolba, et al.
Neurology
|
September 25, 1999
Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial
B Kremer, C M Clark, E W Almqvist, et al.
Journal of Circulating Biomarkers
|
March 15, 2021
Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer
David Lu, Rachel Krupa, Melissa Harvey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Chadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
Page
of 25